Avid Bioservices Inc reports results for the quarter ended in July - Earnings Summary

Avid Bioservices

07/09/2023 22:01

* Avid Bioservices Inc  CDMO.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in July. The
mean expectation of four analysts for the quarter was for a loss
of 3 cents per share.
    * Revenue rose 2.8% to $37.73 million from a year ago;
analysts
expected $36.09 million. 
    * Avid Bioservices Inc's reported EPS for the quarter was a
loss
of 3 cents​.
    * The mean earnings estimate of analysts had fallen by
about 283.3% in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Avid Bioservices Inc shares had fallen by 12.7% this
quarter and
lost 11.4% so far this year.
    * The company reported a quarterly loss of $2.09 million.
    * Wall Street's median 12-month price target for Avid
Bioservices
Inc is $20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
September 7 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jul. 31 2023      -0.03          -0.03          Met
 Apr. 30 2023      0.00           0.00           Met
 Jan. 31 2023      -0.03          0.01           Beat
 Oct. 31 2022      0.00           -0.02          Missed